Uncertainty Over BRCA Testing Reimbursement Remains
This article was originally published in The Gray Sheet
Executive Summary
In recently updated clinical lab fee schedule rates, Medicare payment for BRCA1 and BRCA2 genetic testing goes down from $2,795 to $1,438, but Myriad Genetics believes the change might be a clerical error, repeating an issue from September.